Research on circadian clock genes in non-small-cell lung carcinoma

NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A

(2017) Peng Yuan et al.   Cell Death & Disease

Research progress on circadian clock genes in common abdominal malignant tumors (Review)

(2017) Sheng‑Li Yang et al.   Oncology Letters

FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer

(2016) D. Kazandjian et al.   CLINICAL CANCER RESEARCH

CRY2 and FBXL3 Cooperatively Degrade c-MYC

(2016) Anne-Laure Huber et al.   MOLECULAR CELL

The circadian gene CRY2 is associated with breast cancer aggressiveness possibly via epigenomic modifications

(2015) Yingying Mao et al.   TUMOR BIOLOGY

Circadian gene variants in cancer

(2014) Nicole M. Kettner et al.   ANNALS OF MEDICINE

Loss of circadian clock gene expression is associated with tumor progression in breast cancer

(2014) Cristina Cadenas et al.   CELL CYCLE

Protumorigenic role of Timeless in hepatocellular carcinoma

(2014) NAHLA ELGOHARY et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Hepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinoma

(2014) SHENG-LI YANG et al.   Oncology Letters

Circadian molecular clocks and cancer

(2013) Fergal C. Kelleher et al.   CANCER LETTERS

Nightshift work and risk of ovarian cancer

(2013) Parveen Bhatti et al.   OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Night Work and the Risk of Cancer Among Men

(2012) M.-E. Parent et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

TIMELESSis overexpressed in lung cancer and its expression correlates with poor patient survival

(2012) Kenya Yoshida et al.   CANCER SCIENCE

Circadian topology of metabolism

(2012) Joseph Bass   NATURE

Entrainment of the Mammalian Cell Cycle by the Circadian Clock: Modeling Two Coupled Cellular Rhythms

(2012) Claude Gérard et al.   PLoS Computational Biology

Regulation of apoptosis by the circadian clock through NF- B signaling

(2011) J. H. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Altered expression of circadian clock genes in head and neck squamous cell carcinoma

(2011) Cheng-Ming Hsu et al.   TUMOR BIOLOGY

Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways

(2010) Aaron E Hoffman et al.   BMC CANCER

Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity

(2010) Z.-L. Zeng et al.   JOURNAL OF BIOCHEMISTRY

The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer

(2010) Corey J. Langer et al.   JOURNAL OF CLINICAL ONCOLOGY

Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population

(2009) Bin Huang et al.   CANCER

Clock-Cancer Connection in Non-Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2

(2009) A. E. Hoffman et al.   CANCER RESEARCH

Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study

(2009) Y. Zhu et al.   CANCER RESEARCH

A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway

(2009) Jasper Mullenders et al.   PLoS One

Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer

(2008) Hideki Tokunaga et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA